Literature DB >> 28721627

Two Chinese pedigrees of Blau syndrome with thirteen affected members.

Di Wu1, Min Shen2.   

Abstract

Blau syndrome (BS) is a rare autosomal dominant autoinflammatory disease characterized by the clinical triad of dermatitis, arthritis, and uveitis. It is caused by mutations in nucleotide-binding oligomerization domain-containing protein-2 (NOD2) gene. BS has been widely reported in Caucasians but cases documented in China are scarce. We reported two Chinese families with BS, which were by far the two largest pedigrees in the Chinese population. We identified two unrelated families with BS. The phenotypes and genotypes of these patients were reviewed and compared with previous cohorts. The proband of the first family was a 32-year-old Chinese Han woman, who had dermatitis, polyarthritis, and intermittent fever since the age of 6, bilateral panuveitis since 12. During her disease course, she lost her vision and developed hand flexion contractures. The proband of the second family was a 36-year-old Chinese Han woman, who had dermatitis and bilateral panuveitis since the age of 7, persistent polyarthritis since 13. Additional 7 and 4 family members were affected in the first and second families, respectively, and pedigree analysis suggested autosomal dominant inheritance. Genetic testing in both families identified the heterozygous c.1000 C > T, R334W mutation in NOD2 gene. Only one patient had recurrent fever as an expanded manifestation beyond the classical triad. BS can occur in multiple ethnic groups including the Chinese Han population. Our 11 adult patients constituted the largest adult cohort of BS ever reported in China. Lack of recognition of BS led to a significant delay in diagnosis. A considerable percentage of patients did not demonstrate the full spectrum of the classical triad, further complicating the diagnosis.

Entities:  

Keywords:  Autoinflammatory disease; Blau syndrome; Camptodactyly; Uveitis

Mesh:

Substances:

Year:  2017        PMID: 28721627     DOI: 10.1007/s10067-017-3758-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.

Authors:  Y Ogura; N Inohara; A Benito; F F Chen; S Yamaoka; G Nunez
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

2.  NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain.

Authors:  Carlos D Rosé; Juan I Aróstegui; Tammy M Martin; Graciela Espada; Lisabeth Scalzi; Jordi Yagüe; James T Rosenbaum; Consuelo Modesto; Maria Cristina Arnal; Rosa Merino; Julia García-Consuegra; María Antonia Carballo Silva; Carine H Wouters
Journal:  Arthritis Rheum       Date:  2009-06

3.  NOD2-associated autoinflammatory disease: a large cohort study.

Authors:  Qingping Yao; Min Shen; Christine McDonald; Felicitas Lacbawan; Rocio Moran; Bo Shen
Journal:  Rheumatology (Oxford)       Date:  2015-06-11       Impact factor: 7.580

4.  CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy.

Authors:  Xiaoju Wang; Helena Kuivaniemi; Gina Bonavita; Lysette Mutkus; Ulrike Mau; Edward Blau; Naohiro Inohara; Gabriel Nunez; Gerard Tromp; Charlene J Williams
Journal:  Arthritis Rheum       Date:  2002-11

5.  NOD2 (CARD15), the first susceptibility gene for Crohn's disease.

Authors:  D P McGovern; D A van Heel; T Ahmad; D P Jewell
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

6.  [Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients].

Authors:  Wei Wang; Min Wei; Hongmei Song; Zhengqing Qiu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2014-12

Review 7.  Blau syndrome, clinical and genetic aspects.

Authors:  Paolo Sfriso; Francesco Caso; Sofia Tognon; Paola Galozzi; Alessandra Gava; Leonardo Punzi
Journal:  Autoimmun Rev       Date:  2012-08-02       Impact factor: 9.754

Review 8.  Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.

Authors:  Qingping Yao
Journal:  Semin Arthritis Rheum       Date:  2013-01-24       Impact factor: 5.532

9.  Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

Authors:  Ikuo Okafuji; Ryuta Nishikomori; Nobuo Kanazawa; Naotomo Kambe; Akihiro Fujisawa; Shin Yamazaki; Megumu Saito; Takakazu Yoshioka; Tomoki Kawai; Hidemasa Sakai; Hideaki Tanizaki; Toshio Heike; Yoshiki Miyachi; Tatsutoshi Nakahata
Journal:  Arthritis Rheum       Date:  2009-01

10.  NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.

Authors:  Haotian Xiang; Ting Zhang; Mengping Chen; Xiaomin Zhou; Zhen Li; Naihong Yan; Shiguang Li; Yu Han; Qiyong Gong; Xuyang Liu
Journal:  Mol Vis       Date:  2012-03-09       Impact factor: 2.367

View more
  2 in total

1.  Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome.

Authors:  Jing Chen; Yi Luo; Mengzhu Zhao; Di Wu; Yunjiao Yang; Wen Zhang; Min Shen
Journal:  Arthritis Res Ther       Date:  2019-11-12       Impact factor: 5.156

2.  Ocular manifestations in Chinese adult patients with NLRP3-associated autoinflammatory disease.

Authors:  Tianli Meng; Di Wu; Yi Luo; Na Wu; Mengzhu Zhao; Min Shen; Weihong Yu
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.